Shenzhen Readline Biotechnology Co., Ltd.
PrivateLast Round
Series C
Feb 21, 2025
Total Funding Raised
$157.56M
Company Overview
Shenzhen Readline Biotechnology Co., Ltd. is a biotechnology company that develops immobilized enzyme catalytic technology and provides active ingredients for the pharmaceutical, cosmetic, and nutritional supplement industries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Readline Biotechnology Co., Ltd. Comparables
Compare Shenzhen Readline Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lansion Biotechnology Co., Ltd. | 89% | |
| Chengdu VACURE Biotechnology Co., Ltd. | 86% | |
| Assure Tech Hangzhou Co Ltd | 78% | |
Shenzhen Readline Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 21, 2025 | ||||
| Series B Extension | Apr 14, 2023 | ||||
| Series B | Dec 9, 2022 | ||||
| Series A Extension | Nov 22, 2021 | ||||
| Series A | Dec 4, 2020 | ||||
Angel | Jun 5, 2019 |
Shenzhen Readline Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series B Extension, Series A Extension, Series B, Series A |
| Synergetic Innovation Fund Management | Series B Extension |
| 深圳市力合科创股份有限公司 | Series A |
| Shenzhen Leaguer Venture Capital | Series A Extension |
| CoBuilder Partners | Series A Extension |
| 松禾资本 (Green Pine Capital Partners) | Series B, Series C, Series A Extension |
| CoStone Capital | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 15, 2026
Grew 18% QoQ, from 40 to 47 employees.
- Jan 21, 2026
Monthly visitors grew 41% MoM.
Shenzhen Readline Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shenzhen Readline Biotechnology Co., Ltd.'s valuation, stock price, and market status.